0 NASDAQ Companies - May 13, 2024Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate UpdateStrong financial position with $157.3 million; runway into 2H 2026 IK-930 program on track to deliver clinical update in 2H […]Read More
0 NASDAQ Companies - May 13, 2024Jamf Announces Launch of Secondary Offering of Common Stock by Selling Stockholders and Related Common Stock RepurchaseMINNEAPOLIS, May 13, 2024 (GLOBE NEWSWIRE) — Jamf (Nasdaq: JAMF), the standard in managing and securing Apple at work, today […]Read More
0 NASDAQ Companies - May 13, 2024Zapata Computing Holdings Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)BOSTON, May 13, 2024 (GLOBE NEWSWIRE) — Zapata Computing Holdings Inc. (“Zapata AI” or the “Company”) (Nasdaq: ZPTA), the Industrial […]Read More
0 NASDAQ Companies - May 13, 2024Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones– Investigational New Drug application for non-small cell lung cancer trial with luvelta cleared by U.S. Food and Drug Administration; […]Read More
0 NASDAQ Companies - May 13, 2024Stran & Company Postpones 2024 First Quarter Earnings Conference CallQuincy, MA, May 13, 2024 (GLOBE NEWSWIRE) — Stran & Company, Inc. (“Stran” or the “Company”) (NASDAQ: SWAG) (NASDAQ: SWAGW), […]Read More
0 NASDAQ Companies - May 13, 2024FlexShopper, Inc. Reports 2024 First Quarter and Year End Financial ResultsBOCA RATON, Fla., May 13, 2024 (GLOBE NEWSWIRE) — FlexShopper, Inc. (Nasdaq:FPAY) (“FlexShopper”), a leading national online lease-to-own (“LTO”) retailer […]Read More
0 NASDAQ Companies - May 13, 2024STRATA Skin Sciences to Participate in the Benchmark Healthcare House Call Virtual 1×1 Investor ConferenceHORSHAM, Pa., May 13, 2024 (GLOBE NEWSWIRE) — STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical […]Read More
0 NASDAQ Companies - May 13, 2024Nyxoah to Release First Quarter 2024 Financial Results on May 14, 2024Nyxoah to Release First Quarter 2024 Financial Results on May 14, 2024 Mont-Saint-Guibert, Belgium – May 13, 2024, 10:30pm CET […]Read More
0 NASDAQ Companies - May 13, 2024Aerovate Therapeutics Announces First Quarter Financial Results and Business HighlightsTopline data expected in June 2024 from Phase 2b portion of the IMPAHCT global Phase 2b/Phase 3 clinical trial of […]Read More
0 NASDAQ Companies - May 13, 2024Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational HighlightsOn track to submit NDA in the second half of 2024 for Tonmya™ for fibromyalgia; pre-NDA meeting with FDA scheduled for […]Read More